Using the high-resolution four-digit genotyping technique, our findings confirmed the crucial role of DRB1*15:01–DQB1*06:02 as an important risk combination (p = 0.004), enhancing its global importance as a risk factor for MS. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.